Extended data The PRADO trial

Published: 11 October 2024| Version 1 | DOI: 10.17632/s94m5k2xys.1
Contributor:
Judith Versluis

Description

Extended data Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Files

Categories

Melanoma

Licence